UPCI Joins ExCell Research Study Using Stem Cells for Leukemia and …
PITTSBURGH, Pennsylvania, and JERUSALEM, Israel, June 15 Gamida-Cell-LTD PITTSBURGH, Pennsylvania , and JERUSALEM, Israel , June 15 — The University of Pittsburgh Cancer Institute (UPCI) and the Gamida Cell – Teva Joint Venture announced today that …
[Read the full article here]Related News:
UPCI Joins ExCell Research Study Using Stem Cells For Leukemia And Lymphoma Patients
Data Monitoring Committee Recommends Continuation Of Phase III Study Of StemEx, A Cord Blood Stem Cell Product, For Leukemia And Lymphoma
Stem cell like progenitor cells could be key to aging slowly: Study